🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Hanmi Pharm. Co., Ltd. (KRX:128940)
South Korea flag South Korea · Delayed Price · Currency is KRW
453,000
+31,000 (7.35%)
Nov 20, 2026, 1:15 PM KST

Hanmi Pharm. Cash Flow Statement

Millions KRW. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
169,554121,315146,23182,79267,025
Depreciation & Amortization
98,80997,33198,45496,84289,086
Loss (Gain) From Sale of Assets
-101.2-27.74-1,769-451.651,062
Asset Writedown & Restructuring Costs
3,0132,4889,1533,794535.2
Loss (Gain) From Sale of Investments
-4,76287.92-2,630-47.09-
Loss (Gain) on Equity Investments
7.459.2-1,2588,5374.02
Provision & Write-off of Bad Debts
3,346-593.891,277723.065,118
Other Operating Activities
53,27463,14024,47643,76692,609
Change in Accounts Receivable
-87,255-61,052-3,21737,286-76,613
Change in Inventory
-37,0351,928-16,903-14,36518,916
Change in Accounts Payable
12,458-10,4385,574-2,7369,794
Change in Other Net Operating Assets
-38,238-20,701-42,852-93,870-5,613
Operating Cash Flow
173,072193,487216,538162,269201,923
Operating Cash Flow Growth
-10.55%-10.64%33.44%-19.64%33.25%

Investing Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-43,025-39,261-27,352-30,378-19,949
Sale of Property, Plant & Equipment
462.7250.862,6001,39786.37
Sale (Purchase) of Intangibles
-32,997-22,768-16,156-20,273-14,199
Investment in Securities
-53,626103,827-138,865-118,609-6,953
Other Investing Activities
-3,974-3,650-3,699-13,545-2,375
Investing Cash Flow
-159,45524,851-183,472-181,408-43,389

Financing Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
142,400431,830134,650230,000102,700
Long-Term Debt Issued
38,00049,000-7,00030,000
Total Debt Issued
180,400480,830134,650237,000132,700
Short-Term Debt Repaid
-193,500-472,330-202,650-116,800-198,800
Long-Term Debt Repaid
-53,234-86,431-37,720-147,240-36,476
Total Debt Repaid
-246,734-558,761-240,370-264,040-235,276
Net Debt Issued (Repaid)
-66,334-77,931-105,720-27,040-102,576
Issuance of Common Stock
0----
Repurchase of Common Stock
--3,280-3,071-3,834-4,874
Dividends Paid
-30,855-12,555-17,996-5,992-5,881
Other Financing Activities
---0--
Financing Cash Flow
-97,190-93,767-126,787-36,867-113,331

Net Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-431.3212,7271,373-5,89017,864
Net Cash Flow
-84,004137,297-92,348-61,89663,067

Free Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
130,048154,226189,186131,890181,974
Free Cash Flow Growth
-15.68%-18.48%43.44%-27.52%65.85%
Free Cash Flow Margin
8.40%10.31%12.69%9.90%15.12%
Free Cash Flow Per Share
10248.7712162.1314906.6710382.3714307.73
Levered Free Cash Flow
2,284132,235156,408193,044159,618
Unlevered Free Cash Flow
12,901147,468174,226207,199169,979

Additional Metrics

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
17,06024,74727,84619,49818,315
Cash Income Tax Paid
46,29022,12031,43229,6326,599
Change in Working Capital
-150,069-90,263-57,397-73,686-53,516